Genetic variations in interleukin-12 related genes in immune-mediated diseases

Journal of Autoimmunity

Volumn 39, Issue 4, 2012, Pages 359-368

  van Wanrooij, R L J ^a   Zwiers, A ^a   Kraal, G ^a   Bouma, G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autoimmune disease; Cytokine; IL 12 polymorphism; Interleukin 12; Interleukin 23; Interleukin 27; Interleukin 35

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA1; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 23P19; INTERLEUKIN 27; INTERLEUKIN 35;

ANKYLOSING SPONDYLITIS; ASTHMA; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; CELIAC DISEASE; CROHN DISEASE; DNA POLYMORPHISM; ENTERITIS; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GRAVES DISEASE; HUMAN; IMMUNOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; INTRACELLULAR SIGNALING; MULTIGENE FAMILY; MULTIPLE SCLEROSIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PSORIASIS; PSORIATIC ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL; TH17 CELL; TH2 CELL; ULCERATIVE COLITIS;

AUTOIMMUNE DISEASES; GENETIC VARIATION; GENOTYPE; HUMANS; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKINS; MULTIGENE FAMILY; RECEPTORS, INTERLEUKIN; TH1 CELLS; TH17 CELLS;

EID: 84869882029     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.06.002     Document Type: Review

References (132)

1. Cotsapas C., Voight B.F., Rossin E., Lage K., Neale B.M., Wallace C., et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet 2011, 7:e1002254.
2. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003, 3:133-146.
3. Stockinger B., Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immunol 2007, 19:281-286.
4. Dardalhon V., Korn T., Kuchroo V.K., Anderson A.C. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 2008, 31:252-256.
5. Wojno E.D., Hunter C.A. New directions in the basic and translational biology of interleukin-27. Trends Immunol 2012, 33:91-97.
6. Chaturvedi V., Collison L.W., Guy C.S., Workman C.J., Vignali D.A. Cutting edge: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol 2011, 186:6661-6666.
7. Collison L.W., Chaturvedi V., Henderson A.L., Giacomin P.R., Guy C., Bankoti J., et al. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 2010, 11:1093-1101.
8. Collison L.W., Delgoffe G.M., Guy C.S., Vignali K.M., Chaturvedi V., Fairweather D., et al. The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol 2012, 13:290-299.
9. Bouma G., Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003, 3:521-533.
10. Strober W., Fuss I.J. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011, 140:1756-1767.
11. Franke A., McGovern D.P., Barrett J.C., Wang K., Radford-Smith G.L., Ahmad T., et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010, 42:1118-1125.
12. Barrett J.C., Hansoul S., Nicolae D.L., Cho J.H., Duerr R.H., Rioux J.D., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40:955-962.
13. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461-1463.
14. Marquez A., Mendoza J.L., Taxonera C., Diaz-Rubio M., de la Concha E.G., Urcelay E., et al. IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction. Inflamm Bowel Dis 2008, 14:1192-1196.
15. Glas J., Seiderer J., Nagy M., Fries C., Beigel F., Weidinger M., et al. Evidence for STAT4 as a common autoimmune gene: rs7574865 is associated with colonic Crohn's disease and early disease onset. PLoS One 2010, 5:e10373.
16. Wang K., Zhang H., Kugathasan S., Annese V., Bradfield J.P., Russell R.K., et al. Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. Am J Hum Genet 2009, 84:399-405.
17. Amre D.K., Mack D.R., Morgan K., Israel D., Deslandres C., Seidman E.G., et al. Association between genome-wide association studies reported SNPs and pediatric-onset Crohn's disease in Canadian children. Hum Genet 2010, 128:131-135.
18. Imielinski M., Baldassano R.N., Griffiths A., Russell R.K., Annese V., Dubinsky M., et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 2009, 41:1335-1340.
19. Schmidt C., Giese T., Ludwig B., Mueller-Molaian I., Marth T., Zeuzem S., et al. Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Inflamm Bowel Dis 2005, 11:16-23.
20. Anderson C.A., Massey D.C., Barrett J.C., Prescott N.J., Tremelling M., Fisher S.A., et al. Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 2009, 136:523-529.
21. Fisher S.A., Tremelling M., Anderson C.A., Gwilliam R., Bumpstead S., Prescott N.J., et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 2008, 40:710-712.
22. Franke A., Balschun T., Karlsen T.H., Hedderich J., May S., Lu T., et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet 2008, 40:713-715.
23. McGovern D.P., Gardet A., Torkvist L., Goyette P., Essers J., Taylor K.D., et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet 2010, 42:332-337.
24. Silverberg M.S., Cho J.H., Rioux J.D., McGovern D.P., Wu J., Annese V., et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 2009, 41:216-220.
25. Szperl A., Saavalainen P., Weersma R.K., Lappalainen M., Paavola-Sakki P., Halme L., et al. Functional polymorphism in IL12B promoter site is associated with ulcerative colitis. Inflamm Bowel Dis 2011.
26. Lee E., Trepicchio W.L., Oestreicher J.L., Pittman D., Wang F., Chamian F., et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 2004, 199:125-130.
27. Krueger G.G., Langley R.G., Leonardi C., Yeilding N., Guzzo C., Wang Y., et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 2007, 356:580-592.
28. Tsunemi Y., Saeki H., Nakamura K., Sekiya T., Hirai K., Fujita H., et al. Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J Dermatol Sci 2002, 30:161-166.
29. Cargill M., Schrodi S.J., Chang M., Garcia V.E., Brandon R., Callis K.P., et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007, 80:273-290.
30. Nair R.P., Ruether A., Stuart P.E., Jenisch S., Tejasvi T., Hiremagalore R., et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol 2008, 128:1653-1661.
31. Smith R.L., Warren R.B., Eyre S., Ho P., Ke X., Young H.S., et al. Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort. J Invest Dermatol 2008, 128:1325-1327.
32. Zhang X.J., Huang W., Yang S., Sun L.D., Zhang F.Y., Zhu Q.X., et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet 2009, 41:205-210.
33. Capon F., Di M.P., Szaub J., Prescott N.J., Dunster C., Baumber L., et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 2007, 122:201-206.
34. Nair R.P., Duffin K.C., Helms C., Ding J., Stuart P.E., Goldgar D., et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 2009, 41:199-204.
35. Filer C., Ho P., Smith R.L., Griffiths C., Young H.S., Worthington J., et al. Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum 2008, 58:3705-3709.
36. Huffmeier U., Lascorz J., Bohm B., Lohmann J., Wendler J., Mossner R., et al. Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. J Invest Dermatol 2009, 129:355-358.
37. Liu Y., Helms C., Liao W., Zaba L.C., Duan S., Gardner J., et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 2008, 4:e1000041.
38. Bowes J., Orozco G., Flynn E., Ho P., Brier R., Marzo-Ortega H., et al. Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Ann Rheum Dis 2011.
39. Jandus C., Bioley G., Rivals J.P., Dudler J., Speiser D., Romero P. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum 2008, 58:2307-2317.
40. Wendling D., Cedoz J.P., Racadot E., Dumoulin G. Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis. Jt Bone Spine 2007, 74:304-305.
41. Danoy P., Pryce K., Hadler J., Bradbury L.A., Farrar C., Pointon J., et al. Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease. PLoS Genet 2010, 6:e1001195.
42. Burton P.R., Clayton D.G., Cardon L.R., Craddock N., Deloukas P., Duncanson A., et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007, 39:1329-1337.
43. Davidson S.I., Wu X., Liu Y., Wei M., Danoy P.A., Thomas G., et al. Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum 2009, 60:3263-3268.
44. Evans D.M., Spencer C.C., Pointon J.J., Su Z., Harvey D., Kochan G., et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011, 43:761-767.
45. Karaderi T., Harvey D., Farrar C., Appleton L.H., Stone M.A., Sturrock R.D., et al. Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series. Rheumatology (Oxford) 2009, 48:386-389.
46. Pimentel-Santos F.M., Ligeiro D., Matos M., Mourao A.F., Sousa E., Pinto P., et al. Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population. Clin Exp Rheumatol 2009, 27:800-806.
47. Rahman P., Inman R.D., Gladman D.D., Reeve J.P., Peddle L., Maksymowych W.P. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum 2008, 58:1020-1025.
48. Reveille J.D., Sims A.M., Danoy P., Evans D.M., Leo P., Pointon J.J., et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010, 42:123-127.
49. Sung I.H., Kim T.H., Bang S.Y., Kim T.J., Lee B., Peddle L., et al. IL-23R polymorphisms in patients with ankylosing spondylitis in Korea. J Rheumatol 2009, 36:1003-1005.
50. Bowes J., Barton A. Recent advances in the genetics of RA susceptibility. Rheumatology (Oxford) 2008, 47:399-402.
51. Brentano F., Ospelt C., Stanczyk J., Gay R.E., Gay S., Kyburz D. Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis. Ann Rheum Dis 2009, 68:143-150.
52. Chabaud M., Durand J.M., Buchs N., Fossiez F., Page G., Frappart L., et al. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999, 42:963-970.
53. Chen-Xu M., Topless R., McKinney C., Merriman M.E., Phipps-Green A., Dalbeth N., et al. Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample sets. Ann Rheum Dis 2012, 71:155-157.
54. Varade J., Ramon L.J., Rodriguez L., Fernandez-Arquero M., Loza-Santamaria E., Jover J.A., et al. IL23R and IL12B genes: susceptibility analysis in rheumatoid arthritis. Ann Rheum Dis 2009, 68:1230-1232.
55. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678.
56. Chang M., Saiki R.K., Cantanese J.J., Lew D., van der Helm-van Mil A.H., Toes R.E., et al. The inflammatory disease-associated variants in IL12B and IL23R are not associated with rheumatoid arthritis. Arthritis Rheum 2008, 58:1877-1881.
57. Invernizzi P. Human leukocyte antigen in primary biliary cirrhosis: an old story now reviving. Hepatology 2011, 54:714-723.
58. Yoshida K., Yang G.X., Zhang W., Tsuda M., Tsuneyama K., Moritoki Y., et al. Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice. Hepatology 2009, 50:1494-1500.
59. Hirschfield G.M., Liu X., Xu C., Lu Y., Xie G., Lu Y., et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009, 360:2544-2555.
60. Liu X., Invernizzi P., Lu Y., Kosoy R., Lu Y., Bianchi I., et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 2010, 42:658-660.
61. Mells G.F., Floyd J.A., Morley K.I., Cordell H.J., Franklin C.S., Shin S.Y., et al. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet 2011, 43:329-332.
62. Abadie V., Sollid L.M., Barreiro L.B., Jabri B. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol 2011, 29:493-525.
63. Nilsen E.M., Jahnsen F.L., Lundin K.E., Johansen F.E., Fausa O., Sollid L.M., et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998, 115:551-563.
64. Leon A.J., Garrote J.A., Blanco-Quiros A., Calvo C., Fernandez-Salazar L., Del V.A., et al. Interleukin 18 maintains a long-standing inflammation in coeliac disease patients. Clin Exp Immunol 2006, 146:479-485.
65. Mention J.J., Ben A.M., Begue B., Barbe U., Verkarre V., Asnafi V., et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 2003, 125:730-745.
66. Dubois P.C., Trynka G., Franke L., Hunt K.A., Romanos J., Curtotti A., et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 2010, 42:295-302.
67. Hunt K.A., Zhernakova A., Turner G., Heap G.A., Franke L., Bruinenberg M., et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 2008, 40:395-402.
68. Romanos J., Barisani D., Trynka G., Zhernakova A., Bardella M.T., Wijmenga C. Six new coeliac disease loci replicated in an Italian population confirm association with coeliac disease. J Med Genet 2009, 46:60-63.
69. Trynka G., Hunt K.A., Bockett N.A., Romanos J., Mistry V., Szperl A., et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011, 43:1193-1201.
70. Seegers D., Borm M.E., van Belzen M.J., Mulder C.J., Bailing J., Crusius J.B., et al. IL12B and IRF1 gene polymorphisms and susceptibility to celiac disease. Eur J Immunogenet 2003, 30:421-425.
71. Nunez C., Dema B., Cenit M.C., Polanco I., Maluenda C., Arroyo R., et al. IL23R: a susceptibility locus for celiac disease and multiple sclerosis?. Genes Immun 2008, 9:289-293.
72. Crawford M.P., Yan S.X., Ortega S.B., Mehta R.S., Hewitt R.E., Price D.A., et al. High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 2004, 103:4222-4231.
73. Lovett-Racke A.E., Trotter J.L., Lauber J., Perrin P.J., June C.H., Racke M.K. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. J Clin Invest 1998, 101:725-730.
74. Comabella M., Khoury S.J. Immunopathogenesis of multiple sclerosis. Clin Immunol 2012, 142:2-8.
75. Lincoln M.R., Montpetit A., Cader M.Z., Saarela J., Dyment D.A., Tiislar M., et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 2005, 37:1108-1112.
76. IL12A MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes Immun 2010, 11:397-405.
77. Sawcer S., Hellenthal G., Pirinen M., Spencer C.C., Patsopoulos N.A., Moutsianas L., et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219.
78. Segal B.M., Constantinescu C.S., Raychaudhuri A., Kim L., Fidelus-Gort R., Kasper L.H. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol 2008, 7:796-804.
79. Zamani M., Spaepen M., Bex M., Bouillon R., Cassiman J.J. Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am J Med Genet 2000, 95:432-437.
80. Murakami S., Okubo K., Tsuji Y., Sakata H., Kikuchi M., Takahashi T., et al. Serum levels of interleukin-12 in Graves' disease and their dynamic changes after surgery. Surg Today 2005, 35:1016-1020.
81. Chu X., Pan C.M., Zhao S.X., Liang J., Gao G.Q., Zhang X.M., et al. A genome-wide association study identifies two new risk loci for Graves' disease. Nat Genet 2011, 43:897-901.
82. Guo T., Yang S., Liu N., Wang S., Cui B., Ning G. Association study of interleukin-12A gene polymorphisms with Graves' disease in two Chinese populations. Clin Endocrinol (Oxf) 2011, 74:125-129.
83. Gavett S.H., O'Hearn D.J., Li X., Huang S.K., Finkelman F.D., Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995, 182:1527-1536.
84. Hofstra C.L., Van A.,I., Hofman G., Kool M., Nijkamp F.P., van Oosterhout A.J. Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. J Immunol 1998, 161:5054-5060.
85. Meyts I., Hellings P.W., Hens G., Vanaudenaerde B.M., Verbinnen B., Heremans H., et al. IL-12 contributes to allergen-induced airway inflammation in experimental asthma. J Immunol 2006, 177:6460-6470.
86. Hirota T., Suzuki Y., Hasegawa K., Obara K., Matsuda A., Akahoshi M., et al. Functional haplotypes of IL-12B are associated with childhood atopic asthma. J Allergy Clin Immunol 2005, 116:789-795.
87. Michel S., Liang L., Depner M., Klopp N., Ruether A., Kumar A., et al. Unifying candidate gene and GWAS Approaches in asthma. PLoS One 2010, 5:e13894.
88. Morahan G., Huang D., Wu M., Holt B.J., White G.P., Kendall G.E., et al. Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children. Lancet 2002, 360:455-459.
89. Movahedi M., Mahdaviani S.A., Rezaei N., Moradi B., Dorkhosh S., Amirzargar A.A. IL-10, TGF-beta, IL-2, IL-12, and IFN-gamma cytokine gene polymorphisms in asthma. J Asthma 2008, 45:790-794.
90. Randolph A.G., Lange C., Silverman E.K., Lazarus R., Silverman E.S., Raby B., et al. The IL12B gene is associated with asthma. Am J Hum Genet 2004, 75:709-715.
91. Chen T., Liang W., Gao L., Wang Y., Liu Y., Zhang L., et al. Association of single nucleotide polymorphisms in interleukin 12 (IL-12A and -B) with asthma in a Chinese population. Hum Immunol 2011, 72:603-606.
92. Moffatt M.F., Gut I.G., Demenais F., Strachan D.P., Bouzigon E., Heath S., et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010, 363:1211-1221.
93. Sleiman P.M., Flory J., Imielinski M., Bradfield J.P., Annaiah K., Willis-Owen S.A., et al. Variants of DENND1B associated with asthma in children. N Engl J Med 2010, 362:36-44.
94. Rahman S., Collins M., Williams C.M., Ma H.L. The pathology and immunology of atopic dermatitis. Inflamm Allergy Drug Targets 2011, 10:486-496.
95. Matsui E., Kaneko H., Fukao T., Teramoto T., Inoue R., Watanabe M., et al. Mutations of the IL-12 receptor beta2 chain gene in atopic subjects. Biochem Biophys Res Commun 1999, 266:551-555.
96. Namkung J.H., Lee J.E., Kim E., Kim S., Kim S., Shin E.S., et al. Association of single nucleotide polymorphisms in the IL-12 (IL-12A and B) and IL-12 receptor (IL-12Rbeta1 and beta2) genes and gene-gene interactions with atopic dermatitis in Koreans. J Dermatol Sci 2010, 57:199-206.
97. Takahashi N., Akahoshi M., Matsuda A., Ebe K., Inomata N., Obara K., et al. Association of the IL12RB1 promoter polymorphisms with increased risk of atopic dermatitis and other allergic phenotypes. Hum Mol Genet 2005, 14:3149-3159.
98. Paternoster L., Standl M., Chen C.M., Ramasamy A., Bonnelykke K., Duijts L., et al. Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis. Nat Genet 2011, 44:187-192.
99. Noble J.A., Valdes A.M., Cook M., Klitz W., Thomson G., Erlich H.A. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996, 59:1134-1148.
100. Trembleau S., Penna G., Bosi E., Mortara A., Gately M.K., Adorini L. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 1995, 181:817-821.
101. Trembleau S., Penna G., Gregori S., Gately M.K., Adorini L. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur J Immunol 1997, 27:2330-2339.
102. Morahan G., Huang D., Ymer S.I., Cancilla M.R., Stephen K., Dabadghao P., et al. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 2001, 27:218-221.
103. Davoodi-Semiromi A., Yang J.J., She J.X. IL-12p40 is associated with type 1 diabetes in Caucasian-American families. Diabetes 2002, 51:2334-2336.
104. Santiago J.L., Martinez A., de La C.H., Fernandez-Arquero M., de la Concha E.G., Urcelay E. Th1 cytokine polymorphisms in spanish patients with type 1 diabetes. Hum Immunol 2005, 66:897-902.
105. Windsor L., Morahan G., Huang D., McCann V., Jones T., James I., et al. Alleles of the IL12B 3'UTR associate with late onset of type 1 diabetes. Hum Immunol 2004, 65:1432-1436.
106. Yang J.M., Nagasaka S., Yatagai T., Nakamura T., Kusaka I., Ishikawa S.E., et al. Interleukin-12p40 gene (IL-12B) polymorphism and Type 1 diabetes mellitus in Japanese: possible role in subjects without having high-risk HLA haplotypes. Diabetes Res Clin Pract 2006, 71:164-169.
107. Barrett J.C., Clayton D.G., Concannon P., Akolkar B., Cooper J.D., Erlich H.A., et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009, 41:703-707.
108. Bergholdt R., Ghandil P., Johannesen J., Kristiansen O.P., Kockum I., Luthman H., et al. Genetic and functional evaluation of an interleukin-12 polymorphism (IDDM18) in families with type 1 diabetes. J Med Genet 2004, 41:e39.
109. Johansson S., Lie B.A., Thorsby E., Undlien D.E. The polymorphism in the 3' untranslated region of IL12B has a negligible effect on the susceptibility to develop type 1 diabetes in Norway. Immunogenetics 2001, 53:603-605.
110. McCormack R.M., Maxwell A.P., Carson D.J., Patterson C.C., Middleton D., Savage D.A. The IL12B 3' untranslated region DNA polymorphism is not associated with early-onset type 1 diabetes. Genes Immun 2002, 3:433-435.
111. Nistico L., Giorgi G., Giordano M., Galgani A., Petrone A., D'Alfonso S., et al. IL12B polymorphism and type 1 diabetes in the Italian population: a case-control study. Diabetes 2002, 51:1649-1650.
112. Morahan G., McKinnon E., Berry J., Browning B., Julier C., Pociot F., et al. Evaluation of IL12B as a candidate type I diabetes susceptibility gene using data from the Type I Diabetes Genetics Consortium. Genes Immun 2009, 10(Suppl. 1):S64-S68.
113. Anderson C.A., Boucher G., Lees C.W., Franke A., D'Amato M., Taylor K.D., et al. Corrigendum: meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011, 43:919.
114. Hrdlickova B., Westra H.J., Franke L., Wijmenga C. Celiac disease: moving from genetic associations to causal variants. Clin Genet 2011, 80:203-313.
115. Franke L., Jansen R.C. eQTL analysis in humans. Methods Mol Biol 2009, 573:311-328.
116. Mielants H., Veys E.M., Cuvelier C., De V.M., Goemaere S., De C.L., et al. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol 1995, 22:2273-2278.
117. Hindorff L.A., Sethupathy P., Junkins H.A., Ramos E.M., Mehta J.P., Collins F.S., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009, 106:9362-9367.
118. Manolio T.A. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010, 363:166-176.
119. Hunt R., Sauna Z.E., Ambudkar S.V., Gottesman M.M., Kimchi-Sarfaty C. Silent (synonymous) SNPs: should we care about them?. Methods Mol Biol 2009, 578:23-39.
120. Di M.P., Di C.A., Laggner U., Chu C.C., Napolitano L., Villanova F., et al. The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-Induced Th17 effector response in humans. PLoS One 2011, 6:e17160.
121. Pidasheva S., Trifari S., Phillips A., Hackney J.A., Ma Y., Smith A., et al. Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q. PLoS One 2011, 6:e25038.
122. Sarin R., Wu X., Abraham C. Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. Proc Natl Acad Sci U S A 2011, 108:9560-9565.
123. Hazlett J., Stamp L.K., Merriman T., Highton J., Hessian P.A. IL-23R rs11209026 polymorphism modulates IL-17A expression in patients with rheumatoid arthritis. Genes Immun 2011.
124. Zwiers A., Kraal L., van de Pouw Kraan T.C., Wurdinger T., Bouma G., Kraal G. Cutting edge: a variant of the IL-23R gene associated with inflammatory bowel disease induces loss of MicroRNA regulation and enhanced protein production. J Immunol 2012, 188:1573-1577.
125. Huang D., Cancilla M.R., Morahan G. Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun 2000, 1:515-520.
126. Zwiers A., Seegers D., Heijmans R., Koch A., Hampe J., Nikolaus S., et al. Definition of polymorphisms and haplotypes in the interleukin-12B gene: association with IL-12 production but not with Crohn's disease. Genes Immun 2004, 5:675-677.
127. Stanilova S., Miteva L. Taq-I polymorphism in 3'UTR of the IL-12B and association with IL-12p40 production from human PBMC. Genes Immun 2005, 6:364-366.
128. Seegers D., Zwiers A., Strober W., Pena A.S., Bouma G. A TaqI polymorphism in the 3'UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 2002, 3:419-423.
129. Muller-Berghaus J., Kern K., Paschen A., Nguyen X.D., Kluter H., Morahan G., et al. Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype. Genes Immun 2004, 5:431-434.
130. Zwiers A., Fuss I.J., Seegers D., Konijn T., Garcia-Vallejo J.J., Samsom J.N., et al. A polymorphism in the coding region of Il12b Promotes IL-12p70 and IL-23 heterodimer formation. J Immunol 2011, 186:3572-3580.
131. Tindall E.A., Hayes V.M. Comprehensive sequence analysis of the human IL23A gene defines new variation content and high rate of evolutionary conservation. DNA Res 2010, 17:117-122.
132. Plaza-Izurieta L., Castellanos-Rubio A., Irastorza I., Fernandez-Jimenez N., Gutierrez G., Bilbao J.R. Revisiting genome wide association studies (GWAS) in coeliac disease: replication study in Spanish population and expression analysis of candidate genes. J Med Genet 2011.